Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Avalon Pharmaceuticals |
---|---|
Information provided by: | Avalon Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00273936 |
The purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic malignancies.
Condition | Intervention | Phase |
---|---|---|
Acute Leukemia Chronic Leukemia Multiple Myeloma Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Waldenstrom's Macroglobulinemia |
Drug: AVN-944 capsules for oral administration |
Phase I |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | A Phase I Trial of AVN-944 in Patients With Advanced Hematologic Malignancies |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Adequate hepatic function as evidenced by:
Exclusion Criteria:
United States, Arizona | |
Arizona Clinical Research Center | |
Tucson, Arizona, United States, 85715 | |
United States, California | |
Stanford Cancer Center | |
Stanford, California, United States, 94305 | |
United States, District of Columbia | |
George Washington University | |
Washington, District of Columbia, United States, 20037 | |
United States, Ohio | |
Ohio State University, James Cancer Hospital Comprehensive Cancer Center | |
Columbus, Ohio, United States, 43210 | |
United States, Oregon | |
Oregon Health and Science University | |
Portland, Oregon, United States, 097239 |
Study ID Numbers: | AVN-944-002 |
Study First Received: | January 6, 2006 |
Last Updated: | January 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00273936 |
Health Authority: | United States: Food and Drug Administration |
Hodgkin's disease Immunoproliferative Disorders Hematologic Neoplasms Hematologic Diseases Blood Protein Disorders Hodgkin lymphoma, adult Blood Coagulation Disorders Lymphoma, small cleaved-cell, diffuse Vascular Diseases Paraproteinemias Hemostatic Disorders Multiple Myeloma |
Leukemia Lymphatic Diseases Waldenstrom Macroglobulinemia Hemorrhagic Disorders Multiple myeloma Waldenstrom macroglobulinemia Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Lymphoma Hodgkin Disease Neoplasms, Plasma Cell |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type Immune System Diseases Cardiovascular Diseases |